HCA Healthcare

NYSE
HCA
Stock
Yield per half year: +18.34%
Dividend yield: 0.7488%
Sector: Healthcare

Company Analysis HCA Healthcare

Download the report: word Word pdf PDF

1. Summary

Advantages

  • The stock's return over the last year (-4.46%) is higher than the sector average (-44.44%).
  • Current debt level 76.01% is below 100% and has decreased over 5 years from 78.16%.

Disadvantages

  • Price (374.19 $) is higher than fair price (292.21 $)
  • Dividends (0.7488%) are below the sector average (1.28%).
  • The company's current efficiency (ROE=-269.6%) is lower than the sector average (ROE=-83.32%)

Similar companies

UnitedHealth Group

Humana

Bristol-Myers

Johnson & Johnson

2. Share price and performance

2.1. Share price

2.3. Market efficiency

HCA Healthcare Healthcare Index
7 days -0.9% -3.9% 2.1%
90 days 15.3% -48.5% 10%
1 year -4.5% -44.4% 12.4%

HCA vs Sector: HCA Healthcare has outperformed the "Healthcare" sector by 39.98% over the past year.

HCA vs Market: HCA Healthcare has significantly underperformed the market by -16.87% over the past year.

Stable price: HCA is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.

Long period: HCA with weekly volatility of -0.0858% over the past year.

3. Summary of the report

3.1. General

P/E: 13.64
P/S: 1.11

3.2. Revenue

EPS 22
ROE -269.6%
ROA 9.95%
ROIC 0%
Ebitda margin 19.68%

4. Fundamental Analysis

4.1. Stock price and price forecast

The fair price is calculated taking into account the Central Bank refinancing rate and earnings per share (EPS)

Above fair price: The current price (374.19 $) is higher than the fair price (292.21 $).

Price is higher than fair: The current price (374.19 $) is 21.9% higher than the fair price.

4.2. P/E

P/E vs Sector: The company's P/E (13.64) is lower than that of the sector as a whole (52.65).

P/E vs Market: The company's P/E (13.64) is lower than that of the market as a whole (61.84).

4.2.1 P/E Similar companies

4.3. P/BV

P/BV vs Sector: The company's P/BV (141.59) is higher than that of the sector as a whole (10.86).

P/BV vs Market: The company's P/BV (141.59) is higher than that of the market as a whole (20.59).

4.3.1 P/BV Similar companies

4.4. P/S

P/S vs Sector: The company's P/S indicator (1.11) is lower than that of the sector as a whole (4.03).

P/S vs Market: The company's P/S indicator (1.11) is lower than that of the market as a whole (15.97).

4.4.1 P/S Similar companies

4.5. EV/Ebitda

EV/Ebitda vs Sector: The company's EV/Ebitda (8.77) is lower than that of the sector as a whole (16.29).

EV/Ebitda vs Market: The company's EV/Ebitda (8.77) is lower than that of the market as a whole (18.41).

5. Profitability

5.1. Profitability and revenue

5.2. Earnings per share - EPS

5.3. Past profitability Net Income

Yield Trend: Rising and has grown by 10.72% over the last 5 years.

Earnings Slowdown: The last year's return (0%) is below the 5-year average return (10.72%).

Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-8.87%).

5.4. ROE

ROE vs Sector: The company's ROE (-269.6%) is lower than that of the sector as a whole (-83.32%).

ROE vs Market: The company's ROE (-269.6%) is lower than that of the market as a whole (42.62%).

5.5. ROA

ROA vs Sector: The company's ROA (9.95%) is higher than that of the sector as a whole (6.38%).

ROA vs Market: The company's ROA (9.95%) is lower than that of the market as a whole (23.26%).

5.6. ROIC

ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (15.07%).

ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (9.15%).

6. Finance

6.1. Assets and debt

Debt Level: (76.01%) is a bit high in relation to assets.

Debt reduction: over 5 years, the debt has decreased from 78.16% to 76.01%.

Excess of debt: The debt is not covered by net income, percentage 785.36%.

6.2. Profit growth and share price

7. Dividends

7.1. Dividend yield vs Market

Low yield: The dividend yield of the company 0.7488% is below the average for the sector '1.28%.

7.2. Stability and increase in payments

Dividend stability: The company's dividend yield 0.7488% has been steadily paid over the past 7 years, DSI=0.93.

Weak dividend growth: The company's dividend yield 0.7488% has been growing weakly or stagnant over the past 5 years. Growth over only 4 years.

7.3. Payout percentage

Dividend Coverage: Current payments from income (11.98%) are at an uncomfortable level.

8. Insider trades

8.1. Insider trading

Insider Buying Exceeds insider sales by 100% over the last 3 months.

8.2. Latest transactions

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

9. Stocks forum HCA Healthcare

9.3. Comments